Assenagon Asset Management S.A. Organogenesis Holdings Inc. Transaction History
Assenagon Asset Management S.A.
- $39.3 Billion
- Q2 2024
A detailed history of Assenagon Asset Management S.A. transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 3,977,124 shares of ORGO stock, worth $10.5 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
3,977,124
Previous 971,674
309.31%
Holding current value
$10.5 Million
Previous $2.76 Million
303.59%
% of portfolio
0.03%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding ORGO
# of Institutions
120Shares Held
62.3MCall Options Held
28.8KPut Options Held
27.9K-
Morgan Stanley New York, NY11.6MShares$30.6 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT11.5MShares$30.4 Million3.27% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$13.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.56MShares$9.41 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA3.07MShares$8.12 Million0.03% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $346M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...